Metropolitan Life Insurance Company (MetLife)’s InnovAge Holding INNV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,260
Closed -$7.55K 2367
2023
Q3
$7.55K Hold
1,260
﹤0.01% 2331
2023
Q2
$9.45K Buy
+1,260
New +$8.64K ﹤0.01% 2329
2023
Q1
Sell
-1,365
Closed -$9.8K 2384
2022
Q4
$9.8K Buy
+1,365
New +$8.77K ﹤0.01% 2286
2021
Q4
Sell
-6,479
Closed -$42.8K 2806
2021
Q3
$42.8K Sell
6,479
-10
-0.2% -$155 ﹤0.01% 2782
2021
Q2
$138K Buy
+6,489
New +$148K ﹤0.01% 2413

Other funds holding INNV

Metropolitan Life Insurance Company (MetLife)'s INNV Position: Q4 2023 in Review

Metropolitan Life Insurance Company (MetLife) sold out of InnovAge Holding (INNV) in Q4 2023, closing a stake of 1,260 shares — an estimated $7.55K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in INNV in Q2 2021 and held it in 5 quarters. The position peaked at $138K in Q2 2021. 45 funds tracked by Wall St. Rank hold INNV as of Q4 2023.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining InnovAge Holding position as of Q4 2023 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 1,260 InnovAge Holding shares in Q4 2023, an estimated $7.55K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in InnovAge Holding in Q2 2021 and held it in 5 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s InnovAge Holding position peaked at $138K in Q2 2021.
  • 45 funds tracked by Wall St. Rank held InnovAge Holding as of Q4 2023.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q4 2023, filed 14 Feb 2024.